Phase i trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (1), 139-145
- https://doi.org/10.1016/0360-3016(92)90993-r
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Sphincter preservation in rectal cancer by local excision and postoperative radiation therapyCancer, 1991
- A Phase I Trial of Preoperative Radiation, Proctectomy, and Endoanal ReconstructionArchives of Surgery, 1990
- Combined modality preoperative therapy in poor prognostic rectal adenocarcinomaRadiotherapy and Oncology, 1988
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: Implications in treatment planning with adjuvant radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum:Clinicopathologic correlation and implications for adjuvant therapyCancer, 1974